{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:27:33Z","timestamp":1762032453791},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.transproceed.2004.01.031","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T11:07:14Z","timestamp":1079694434000},"page":"S302-S308","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["Cyclosporine in thoracic organ transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"N.R","family":"Banner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2004.01.031_BIB1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.1956.02960390027008","article-title":"Successful homotransplantation of the kidney between identical twins","volume":"160","author":"Merrill","year":"1956","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(60)90343-3","article-title":"The rejection of renal homografts: inhibition in dogs by 6-mercaptopurine","volume":"1","author":"Calne","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM196306132682401","article-title":"Prolonged survival of human kidney homografts by immunosuppressive drug therapy","volume":"268","author":"Murray","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB4","first-page":"1271","article-title":"The operation. A human cardiac transplant","volume":"41","author":"Barnard","year":"1967","journal-title":"S Afr Med J"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(74)90480-2","article-title":"Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes","volume":"1","author":"Caves","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00007890-197611000-00011","article-title":"Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome","volume":"22","author":"Bieber","year":"1976","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM198010233031709","article-title":"trustees say no to heart transplants","volume":"303","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB8","series-title":"Cyclosporin","first-page":"1","article-title":"Inhibitory effects of cyclosporin A on lymphocyte activation","author":"Kay","year":"1989"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB11","first-page":"986","article-title":"Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial","volume":"2","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198310063091401","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2004.01.031_BIB13","first-page":"2546","article-title":"Cyclosporine in cardiac transplantation","volume":"15","author":"Oyer","year":"1983","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1378\/chest.90.1.29","article-title":"Cardiac transplant patient at one year. Cyclosporine vs conventional immunosuppression","volume":"90","author":"Emery","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thx.24.4.383","article-title":"Transplantation of the heart and both lungs. I. Historical review","volume":"24","author":"Cooper","year":"1969","journal-title":"Thorax"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0003-4975(10)65544-0","article-title":"A review of 23 human lung transplantations by 20 surgeons","volume":"9","author":"Wildevuur","year":"1970","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM198203113061001","article-title":"Heart-lung transplantation","volume":"306","author":"Reitz","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM198605013141802","article-title":"Unilateral lung transplantation for pulmonary fibrosis","volume":"314","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1053-2498(03)00186-4","article-title":"The registry of the International Society for Heart and Lung Transplantation","volume":"22","author":"Taylor","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB20","doi-asserted-by":"crossref","unstructured":"Banner NR, Lyster H, Yacoub MH: Clinical immunosuppression using the calcineurin-inhibitors ciclosporin and tacrolimus. In Cohen P, (ed), Handbook of Experimental Pharmacology. Berlin: Springer-Verlag (in press)","DOI":"10.1007\/3-540-26670-4_12"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB21","series-title":"Lung transplantation","first-page":"185","article-title":"Immunological mechanisms of graft injury","author":"Rose","year":"2003"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007691-199512000-00017","article-title":"Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel","volume":"17","author":"Oellerich","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine-associated end-stage nephropathy after cardiac transplantation","volume":"63","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB27","series-title":"Lung Transplantation","first-page":"261","article-title":"Cytomegalovirus infection","author":"Banner","year":"2003"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB29","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"issue":"suppl 8","key":"10.1016\/j.transproceed.2004.01.031_BIB32","first-page":"S29","article-title":"Infectious tolerance? Mechanisms and implications","volume":"72","author":"Lechler","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB33","series-title":"Transplant-associated coronary artery disease","first-page":"1","article-title":"Coronary arterial disease in the cardiac allograft","author":"Banner","year":"2001"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB34","series-title":"Lung Transplantation","first-page":"243","article-title":"Chronic lung allograft dysfunction","author":"Hertz","year":"2003"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB35","series-title":"Lung Transplantation","first-page":"205","article-title":"Pharmacological Immunosuppression","author":"Banner","year":"2003"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB36","first-page":"221","article-title":"The use of cyclosporine, azathioprine and antithymocyte globulin with or without low dose steroids for immunosuppression of cardiac transplant patients","volume":"17","author":"Yacoub","year":"1985","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB37","series-title":"Clinical Transplants 1987","first-page":"17","article-title":"Cardiac transplantation at, Harefield Hospital","author":"Banner","year":"1987"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB38","first-page":"III100","article-title":"Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens","volume":"80","author":"Gao","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB39","first-page":"550","article-title":"Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation","volume":"11","author":"Keogh","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation","volume":"18","author":"Taylor","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00007890-199801150-00021","article-title":"Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group","volume":"65","author":"Mentzer","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB46","first-page":"795","article-title":"Tacrolimus","volume":"16","author":"Meiser","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/clpt.1993.132","article-title":"Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation","volume":"54","author":"Lindholm","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2125.1992.tb05657.x","article-title":"Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation","volume":"34","author":"Best","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1018923912135","article-title":"Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation","volume":"11","author":"Mueller","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-200101150-00012","article-title":"Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients","volume":"71","author":"Eisen","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00063030-200115050-00001","article-title":"C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation","volume":"15","author":"Levy","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.031_BIB54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450400082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450400082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T10:20:33Z","timestamp":1550139633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113450400082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S004113450400082X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.031","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}